Th17 cells in Bulgarian children with chronic obstructive lung diseases
Main Article Content
Keywords
Th17 cells, IL-17, Childhood asthma, Severe asthma, Controlled asthma, Cystic fibrosis
Abstract
Introduction and objectives: Th17 lymphocytes are now widely believed to be critical in various chronic pulmonary diseases. However, there is still a small number of investigations regarding children. We aimed to assess the percentage of Th17 lymphocytes and IL-17A in peripheral blood of children with chronic obstructive lung diseases.
Patients and methods: We included a total of 42 children: 20 with bronchial asthma (BA), 12 with cystic fibrosis (CF) and 10 healthy children without a history of allergies, aged 4-17 years. Th17 cells (CD3+CD4+CD161+CCR6+) were determined in peripheral blood by flow cytometry. The concentration of serum IL-17A was measured by ELISA.
Results: The BA patients had a significantly higher percentage of Th17 (12.40 ± 1.16%) compared to the CF children (7.64 ± 0.87%, p = 0.0035) and healthy (7.25 ± 0.45%, p = 0.008). Stratifying the BA group, we found higher levels of Th17 in patients with severe BA (p = 0.03), whereas patients with moderate BA had Th17 cells close to those in CF and healthy children. We found that patients with better control of BA had Th17 closer to those with CF (p = 0.98) than BA children with poor control (p < 0.001) (post hoc, Bonferroni correction). CF patients with concomitant P. aeruginosa infection showed slightly higher percentages of Th17 cells than those without infection (8.08 ± 3.09% vs. 6.25 ± 2.42%, p = 0.294).
Conclusions: The percentage of Th17 cells was significantly increased in the peripheral blood of children with severe BA compared to the children with moderate BA, which suggests that the former could possibly benefit from future target therapies.
References
2. Guibas GV, Mathioudakis AG, Tsoumani M, Tsabouri S. Relationship of allergy with asthma: there are more than the allergy ‘‘eggs’’ in the asthma ‘‘basket’’. Front Pediatrics. 2017;5:92, http://dx.doi.org/10.3389/fped.2017.00092.
3. Lynch JP, Ferreira MA, Phipps S. Th2/Th17 reciprocal regulation: twists and turns in the complexity of asthma phenotypes. Ann Transl Med. 2016;4 Suppl 1:S59, http://dx.doi.org/10.21037/atm.2016.10.69.
4. Landgraf-Rauf K, Anselm B, Schaub B. The puzzle of immune phenotypes of childhood asthma. The puzzle of immune phenotypes of childhood asthma. Mol Cell Pediatrics. 2016;3:27, http://dx.doi.org/10.1186/s40348-016-0057-3.
5. Bhakta N, Erle D. IL-17 and ‘‘TH2-high’’ asthma: adding fuel to the fire? J Allergy Clin Immunol. 2014;134:1187-8, http://dx.doi.org/10.1016/j.jaci.2014.07.034.
6. Wong CK, Ho CY, Ko FW, Chan CH, Ho AS, Hui DS, et al. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN- amma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol. 2001;125:177-83. PMCID: PMC1906135.
7. Aujla SJ, Alcorn JF. T(H)17 cells in asthma and inflammation. Biochim Biophys Acta. 2018;1810:1066-79, http://dx.doi.org/10.1016/j.bbagen.2011.02.002.
8. Kudo M, Melton AC, Chen C, Engler MB, Huang KE, Ren X, et al. IL-17A produced by alphabeta T cells drives airway hyperresponsiveness in mice and enhances mouse and human airway smooth muscle contraction. Nat Med. 2012;18:547-54, http://dx.doi.org/10.1038/nm.2684.
9. McKinley L, Alcorn JF, Peterson A, Dupont RB, Kapadia S, Logar A, et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol. 2008;181:4089-97. PMCID: PMC3638757.
10. Newcomb DC, Peebles RS Jr. Th17-mediated inflammation in asthma. Curr Opin Immunol. 2013;25:755-60, http://dx.doi.org/10.1016/j.coi.2013.08.002.
11. Stout JW, Visness CM, Enright P, et al. Classification of asthma severity in children the contribution of pulmonary function testing. Arch Pediatr Adolesc Med. 2006;160:844-50, http://dx.doi.org/10.1001/archpedi.160.8.844.
12. Lazova S, Petrova G, Miteva D, Papochieva V, Perenovska P. Small airway indices, bronchodilator response and asthma control in children. Eur Respir J. 2014;44 Suppl. 58:3516.
13. Balfour-Lynn IM, Elborn JS. ‘‘CF asthma’’: what is it and what do we do about it? Thorax. 2002;57:742-8.
14. Petrova G, Perenovska P, Strateva T, Mitov I. Cytology and microbiology investigation of sputum in chronic respiratory diseases in childhood. Bulgarian Med J. 2008;2:27-33.
15. Petrova G, Perenovska P, Lesichkova S, Miteva D, Cholakova K, Strateva T. Monitoring the titer of antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis - clinical application. Thoracic Med. 2017;2:44-55.
16. Petrova G, Perenovska P, Lesichkova S, Lazova S, Miteva D, Cholakova K, et al. Pseudomonas aeruginosa infection in patients with cystic fibrosis - concordance between the immunology and microbiology test results. Nauka Pulmol. 2017;3:5-14.
17. Kerzel S, Dehne J, Rogosch T, Schaub B, Maier RF, Zemlin M. Th17 cell frequency in peripheral blood from children with allergic asthma correlates with the level of asthma control. J Pediatr (Rio J). 2012;161:1172-4, http://dx.doi.org/10.1016/j.jpeds.2012.07.051.
18. Krasimirova E, Velikova T, Ivanova-Todorova E, TumangelovaYuzeir K, Kalinova D, Boyadzhieva V, et al. Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients. World J Exp Med. 2017;7:58-96, http://dx.doi.org/10.5493/wjem.v7.i3.84.
19. Irvin C, Zafar I, Good J, Rollins D, Christianson C, Gorska MM, et al. Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma. J Allergy Clin Immunol. 2014;134:1175-86, http://dx.doi.org/10.1016/j.jaci.2014.05.038.
20. Aujla SJ, Dubin PJ, Kolls JK. Interleukin-17 in pulmonary host defense. Exp Lung Res. 2007;33:507-18, http://dx.doi.org/10.1080/01902140701756604.
21. Kuiper S, Muris JW, Dompeling E, van Schayck CP, Schonberger HJ, Wesseling G, et al. Association between first-degree familial predisposition of asthma and atopy (total IgE) in newborns. Clin Exp Allergy. 2006;36:594-601, http://dx.doi.org/10.1111/j.1365-2222.2006.02467.x.
22. Milner JD. IL-17 producing cells in host defense and atopy. Curr Opin Immunol. 2011;23:784-8, http://dx.doi.org/10.1016/j.coi.2011.09.006.
23. Barczyk A, Pierzchala W, Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med. 2003;97:726-33. PMID: 12814161.
24. Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, Dupont LJ, et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res. 2006;7:135, http://dx.doi.org/10.1186/1465-9921-7-135.
25. Doe C, Bafadhel M, Siddiqui S, Desai D, Mistry V, Rugman P, et al. Expression of the T helper 17-associated cytokines IL17A and IL-17F in asthma and COPD. Chest. 2010;138:1140-7, http://dx.doi.org/10.1378/chest.09-3058.
26. Oboki K, Ohno T, Saito H, Nakae S. Th17 and allergy. Allergol Int. 2008;57:121-34, http://dx.doi.org/10.2332/allergolint. R-07-160.
27. Agache I, Ciobanu C, Agache C, Anghel M. Increased serum IL-17 is an independent risk factor for severe asthma. Respir Med. 2010;104:1131-7, http://dx.doi.org/10.1016/j.rmed.2010.02.018.
28. Schnyder-Candrian S, Togbe D, Couillin I, Mercier I, Brombacher F, Quesniaux V, et al. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med. 2006;203:2715-25, http://dx.doi.org/10.1084/jem.20061401.
29. Voehringer D, Reese TA, Huang X, Shinkai K, Locksley RM. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J Exp Med. 2006;203:1435-46, http://dx.doi.org/10.1084/jem.20052448.
30. Lange NE, Litonjua A, Hawrylowicz CM, Weiss S. Vitamin D the immune system and asthma. Expert Rev Clin Immunol. 2009;5:693-702, http://dx.doi.org/10.1586/eci.09.53.
31. Lazova S, Miteva D, Perenovska P. Measuring the bronchial reversibility in asthmatic children. EUS. 2016;12:24-8.
32. Tsvetkova-Vicheva VM, Gecheva SP, Komsa-Penkova R, Velkova AS, Lukanov TH. IL-17 producing T cells correlate with polysensitization but not with bronchial hyperresponsiveness in patients with allergic rhinitis. Clin Transl Allergy. 2014;4:3, http://dx.doi.org/10.1186/2045-7022-4-3.
33. Dubin PJ, McAllister F, Kolls JK. Is cystic fibrosis a TH17 disease? Inflamm Res. 2007;56:221-7, http://dx.doi.org/10.1007/s00011-007-6187-2.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.